Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.50
+1.94 (0.93%)
AAPL  273.54
+1.40 (0.51%)
AMD  213.71
-0.13 (-0.06%)
BAC  51.18
+0.77 (1.53%)
GOOG  312.25
+1.32 (0.43%)
META  649.25
+9.95 (1.56%)
MSFT  399.19
+10.19 (2.62%)
NVDA  195.96
+3.11 (1.61%)
ORCL  151.58
+5.44 (3.72%)
TSLA  414.65
+5.27 (1.29%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.